Backed by Bayer's Leaps, Boston-based Cellino lands $80M for cell therapy-in-box

Backed by Bayer's Leaps, Boston-based Cellino lands $80M for cell therapy-in-box

Source: 
Endpoints
snippet: 

Cellino landed $80 million in a Series A led by Leaps by Bayer, the big pharma’s investment arm, 8VC and the Humboldt Fund. Felicis Ventures and existing investors The Engine and Khosla Ventures also contributed. So far, the company has raised $96 million to date.